Redeye updates its view of Nanexa following the Q3 report and recent events in the company. We still see significant upside in the company and argue that there is good potential for positive share price momentum once the selling pressure in the share has eased and we move into a momentous 2024.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Nanexa Q3 - Focused approach

© Modular Finance, source Nordic Press Releases